Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Net margin0.5%6.6%0.2%
Returns
Return on equity1.1%13.2%0.4%
Efficiency
Asset turnover+0.1×0.0×0.0×-0.1×0.0×
Liquidity
Current ratio3.5×-0.6×3.6×-0.1×3.3×+0.2×+1.2×4.1×+1.4×
Leverage
Debt-to-equity0.2×0.0×0.3×-0.2×0.1×-0.2×0.1×-0.3×0.1×-0.3×
Per Share
Book value per share$1.91-0.5%$2.30+15.4%$1.95-6.3%$1.74-12.4%$1.92-8.8%
Valuation
Market capitalization$312.68M-23.7%$657.4M+63.4%$535.34M+41.2%$438.91M+18.9%$547.9M+47.4%
Price / sales0.6×-0.3×1.2×+0.3×1.2×+0.3×+0.2×1.2×+0.3×
Price / book1.3×-0.4×2.2×+0.7×2.1×+0.7×1.9×+0.5×2.3×+0.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Organogenesis Holdings Inc.'s profit margins?
Organogenesis Holdings Inc. (ORGO) runs a 75.9% gross margin and a 0.5% operating margin, with a 0.5% net margin.
Where do Organogenesis Holdings Inc.'s ratios come from?
Every ratio is computed from Organogenesis Holdings Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.